Francesco Paoloni - A.O.U. Ospedali Riuniti, Università Politecnica delle Marche

Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual International Conference (2024): 1-4

Cited0Views0EIWOSBibtex

Differential Impact of Lipid Profile According to Neutrophil-to-lymphocyte Ratio Status in Patients with Advanced Cancer Treated with Immunotherapy

Fabiana Perrone,Federica Pecci,Michele Maffezzoli,Giulia Claire Giudice,Valeria Cognigni,Giulia Mazzaschi,Luca Cantini, Luca Santamaria,Francesco Paoloni,Marco Luigi Bruno Rocchi,Matilde Coriano,Alessandro Acunzo,Federico Quaini,Marcello Tiseo,Saini S. Kamal,Rossana Berardi,Sebastiano Buti

IMMUNOTHERAPYno. 13 (2024): 859-868

Cited0Views0WOSBibtex

Pan-cancer G2C-Pro: A Two-Stage Gaussian Clustering to Prognostically Stratify Patients with Advanced Tumors Treated with Immune Checkpoint Inhibitors

Francesco Paoloni,Federica Pecci,Giulia Bruschi,Elisabetta Tola,Agnese Sbrollini, Tommaso Galassi,Alessandra Borgheresi,Valeria Cognigni,Luca Cantini, Luca Santamaria, Mariangela Gualtieri,Valentina Lunerti,Veronica Agostinelli,Andrea Agostini,Giulia Mentrasti,Andrea Giovagnoni,Laura Burattini,Rossana Berardi

Journal of Clinical Oncologyno. 16_suppl (2024): e13605-e13605

Cited0Views0Bibtex

Safety of Extended Interval Dosing Immune Checkpoint Inhibitors: a Multicenter Cohort Study

Luca Cantini,Francesco Paoloni,Federica Pecci,Francesco Spagnolo,Carlo Genova,Enrica Teresa Tanda,Sophie Aerts,Sara Elena Rebuzzi,Giuseppe Fornarini,Federica Zoratto,Sara Fancelli,Alessio Lupi,Carminia Maria Della Corte,Alessandro Parisi,Chiara Bennati,Cinzia Ortega,Francesco Atzori,Pier Luigi Piovano,Corrado Orciuolo,Michele De Tursi,Michele Ghidini,Andrea Botticelli,Simone Scagnoli,Lorenzo Belluomini,Rita Leporati,Antonello Veccia,Anna Maria Di Giacomo,Lucia Festino,Diego Cortinovis,Mirko Acquati,Marco Filetti,Raffaele Giusti,Marco Tucci,Maria Chiara Sergi,Mattia Garutti,Fabio Puglisi,Sara Manglaviti,Fabrizio Citarella,Matteo Santoni,Erika Rijavec,Giuseppe Lo Russo,Daniele Santini,Alfredo Addeo,Lorenzo Antonuzzo,Alice Indini,Marco Bruno Luigi Rocchi,Alessio Cortellini,Francesco Grossi,Paolo Antonio Ascierto,Joachim G. J. V. Aerts,Rossana Berardi

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEno. 7 (2023): 796-804

Cited6Views0WOSBibtex

Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers

Alessandro Parisi,Francesca Rossi,Chiara De Filippis,Francesco Paoloni,Cristiano Felicetti,Alex Mammarella,Federica Pecci,Alessio Lupi,Rossana Berardi

OncoTargets and therapy (2023): 585-613

Cited1Views0WOSBibtex

Old but Gold: the Role of Drug Combinations in Improving Response to Immune Check-Point Inhibitors in Thoracic Malignancies Beyond NSCLC

Luca Cantini,Federica Pecci,Filippo Merloni,Andrea Lanese,Edoardo Lenci,Francesco Paoloni,Joachim G J V Aerts,Rossana Berardi

Exploration of targeted anti-tumor therapy (2021)

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn